CellnLife Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
35
- Latest Deal Type
-
Out of Business
CellnLife General Information
Description
Operator of a biotech company intended to extend a healthy lifespan and improve quality of life. The company's technology creates treatments for side effects and rare diseases that can occur before and after bone marrow transplants, enabling patients with healthy lives and wellness with unmet medical needs.
Contact Information
Website
www.cellnlife.comCorporate Office
- 8th floor 50, Digital-ro 33-gil
- Guro-gu
- Seoul, 08377
- South Korea
Corporate Office
- 8th floor 50, Digital-ro 33-gil
- Guro-gu
- Seoul, 08377
- South Korea
CellnLife Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | Completed | Out of Business | ||||
| 5. Early Stage VC (Series B) | 31-May-2021 | Completed | Clinical Trials - Phase 1 | |||
| 4. Early Stage VC (Series A) | 30-Sep-2020 | Completed | Clinical Trials - Phase 1 | |||
| 3. Seed Round | 19-Dec-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |
CellnLife Patents
CellnLife Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022019649-A1 | Anticancer composition comprising stem cell with enhanced efficacy | Inactive | 22-Jul-2020 | ||
| WO-2022019403-A1 | S-i-s culture method for producing high-efficacy stem cells | Inactive | 22-Jul-2020 | ||
| WO-2021230678-A1 | Cell engraftment promoting composition comprising stem cell having enhanced efficacy | Inactive | 13-May-2020 | ||
| EP-3527982-A1 | Method for selecting high-efficacy stem cell by using downregulation in expression or activity of socs | Inactive | 17-Oct-2016 | ||
| EP-3527982-A4 | Method for selecting high-efficacy stem cell by using downregulation in expression or activity of socs | Inactive | 17-Oct-2016 | G01N33/5073 |
CellnLife Signals
CellnLife FAQs
-
When was CellnLife founded?
CellnLife was founded in 2018.
-
Where is CellnLife headquartered?
CellnLife is headquartered in Seoul, South Korea.
-
What is the size of CellnLife?
CellnLife has 35 total employees.
-
What industry is CellnLife in?
CellnLife’s primary industry is Therapeutic Devices.
-
Is CellnLife a private or public company?
CellnLife is a Private company.
-
What is CellnLife’s current revenue?
The current revenue for CellnLife is .
-
How much funding has CellnLife raised over time?
CellnLife has raised $4.24M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process